Shariff Atiqulla, Sridhar Sathvik Belagodu, Bittar Hana Rami, Hamad Ahed, Ahmed Reem, Kadour Ghaidaa
Department of Clinical Pharmacy and Pharmacology, RAK College of Pharmaceutical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates.
J Res Pharm Pract. 2019 Apr-Jun;8(2):64-68. doi: 10.4103/jrpp.JRPP_18_58.
Hypoglycemia is the most common complication of the treatment for diabetes mellitus. Various factors predispose an individual for drug-induced hypoglycemia. The aim of this study was to explore the relative frequency and likely predisposing factors for drug-induced hypoglycemia among type-2 diabetic patients in the United Arab Emirates (UAE).
In this cross-sectional survey-based study which was conducted from February to April 2018 in two local community pharmacies in the UAE, diabetic patients underwent a structured interview on their diabetes mellitus status and management and specific open-ended questions related to hypoglycemic symptoms that they might have experienced and the occurrence of symptoms. Collected data were used to estimate the relative frequency of drug-induced hypoglycemia and to identify the probable predisposing factors and their contribution in causing hypoglycemia using relative risk, Chi-square test, and Fisher's exact test.
The relative frequency of drug-induced hypoglycemia in our study was 46.25%. Patients' age of ≥65 years, duration of diabetes mellitus for more than 1 year, patients with more than one comorbid condition, and patients using more than one antidiabetic medication were predisposing for developing drug-induced hypoglycemia.
The relative frequency of drug-induced hypoglycemia in a nontrial environment which lacks the special cares routinely provided in drug development clinical trials is high. We suggest that more attention should be paid to identify, prevent, and manage drug-induced hypoglycemia in type-2 diabetic patients who have more than 1 year of diabetes, more than one comorbidity, using more than one antidiabetic medication, and elderly.
低血糖是糖尿病治疗最常见的并发症。多种因素使个体易发生药物性低血糖。本研究的目的是探讨阿拉伯联合酋长国(阿联酋)2型糖尿病患者中药物性低血糖的相对发生率及可能的诱发因素。
在2018年2月至4月于阿联酋两家当地社区药房开展的这项基于横断面调查的研究中,糖尿病患者接受了关于其糖尿病病情及管理情况的结构化访谈,以及与他们可能经历的低血糖症状及症状发生情况相关的特定开放式问题。收集的数据用于估计药物性低血糖的相对发生率,并使用相对危险度、卡方检验和费舍尔精确检验来确定可能的诱发因素及其在导致低血糖中的作用。
我们研究中药物性低血糖的相对发生率为46.25%。年龄≥65岁的患者、糖尿病病程超过1年的患者、患有不止一种合并症的患者以及使用不止一种抗糖尿病药物的患者易发生药物性低血糖。
在缺乏药物研发临床试验中常规提供的特殊护理的非试验环境中,药物性低血糖的相对发生率很高。我们建议,对于糖尿病病程超过1年、患有不止一种合并症、使用不止一种抗糖尿病药物的2型糖尿病患者以及老年患者,应更加关注识别、预防和管理药物性低血糖。